Skip to ContentSkip to Navigation
About us Practical matters How to find us A.A. (Anna) de Bruyn-Rybczynska, PhD


Detecting therapy-guiding RNA aberrations in platelets of non-small cell lung cancer patients

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients

An all-in-one transcriptome-based assay to identify therapy-related biomarkers in lung cancer

Detecting therapy-guiding aberrations in platelets and plasma at the transcriptome level in non-small-cell lung cancer

Avenues to molecular imaging of dying cells: Focus on cancer

A comprehensive RNA-based assay for treatment prediction in non-small cell lung cancer patients

All-in-one RNA-based assay to detect therapeutic biomarkers in lung cancer

Sigma-1 agonist binding in the aging rat brain: A microPET study with [11C]SA4503

Potential applications for sigma receptor ligands in cancer diagnosis and therapy

[18F]-(fluoromethoxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)propan-2-ol ([18F FPTC) a novel PET-ligand for cerebral beta-adrenoceptors

Read more